Judge Allison Burroughs conducted a 2 1/2-week bench trial entirely by Zoom, concluding Friday that former University of Connecticut researchers don't belong on Astellas Pharma patents.
February 05, 2021 at 08:24 PM
1 minute read
Former researchers at the University of Connecticut’s Stem Cell Institute helped test a breakthrough in regenarative medicine. But they did not invent it and should not be listed on patents that describe it, a federal judge has ruled.
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Breaking news and trends for law firm and legal departments about the evolving federal regulations in a volatile political climate.
Michael Morin, left, and David Frazier, right, of Latham & Watkins.
